[1] Jiao J, Li X, Zhang S, Liu J, Di D, Zhang Y, et al. (2016) Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release. Materials Science and Engineering: C;67:26-33.
[2] Zhang J, Yuan ZF, Wang Y, Chen WH, Luo GF, Cheng SX, et al. (2013) Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. Journal of the American Chemical Society;135: 5068-5073.
[3] Jiao J, Li X, Zhang S, Liu J, Di D, Zhang Y, et al. (2016) Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release. Materials Science & Engineering C;67:26-33.
[4] Zhao Q, Jia L, Zhu W, Sun C, Di D, Ying Z, et al. (2015) Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Acta Biomaterialia;23:147-156.
[5] Qin Y, Chen J, Bi Y, Xu X, Zhou H, Gao J, et al. (2015) Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle. Acta Biomaterialia;17:201-209.
[6] Li X, Feng X, Sun C, Liu Y, Zhao Q, Wang S. (2020) Mesoporous carbon‑manganese nanocomposite for multiple imaging guided oxygen-elevated synergetic therapy. Journal of Controlled Release;319:104-118.
[7] Cheng R, Feng F, Meng F, Deng C, Feijen J, Zhong Z. (2011) Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. Journal of Controlled Release;152:2-12.
[8] Tang F, Li L, Chen D. (2012) Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Advanced Materials;24:1504-1534.
[9] Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J, et al. (2015) Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine : Nanotechnology, Biology, and Medicine;11:313-327.
[10] Zhao Q, Geng H, Wang Y, Gao Y, Huang J, Wang Y, et al. (2014) Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery. ACS Applied Materials & Interfaces;6:20290-20299.
[11] Moghaddam SPH, Yazdimamaghani M, Ghandehari H. (2018) Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery. Journal of Controlled Release;282:62-75.
[12] Wu Y, Lu J, Mao Y, Jiang T, Zhao Q, Wang S. (2020) Composite phospholipid-coated hollow mesoporous silica nanoplatform with multi-stimuli responsiveness for combined chemo-photothermal therapy. Journal of Materials Science;55:5230-5246.
[13] Radu DR, Lai C-Y, Jeftinija K, Rowe EW, Jeftinija S, Lin VS-Y. (2004) A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. Journal of the American Chemical Society;126:13216-13217.
[14] Yang Y, Lin Y, Di D, Zhang X, Wang D, Zhao Q, et al. (2017) Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy. J Colloid Interface Sci;508:323-31.
[15] Zhao Q, Wang C, Liu Y, Wang J, Gao Y, Zhang X, et al. (2014) PEGylated mesoporous silica as a redox-responsive drug delivery system for loading thiol-containing drugs. International Journal of Pharmaceutics;477:613-622.
[16] Sun YL, Yang BJ, Zhang SXA, Yang YW. (2012) Cucurbit [7] uril Pseudorotaxane‐Based Photoresponsive Supramolecular Nanovalve. Chemistry-A European Journal;18:9212-9216.
[17] Han N, Zhao Q, Wan L, Wang Y, Gao Y, Wang P, et al. (2015) Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance. ACS Applied Materials & Interfaces;7:3342-3351.
[18] Tannergren C, Bergendal A, Lennernäs H, Abrahamsson B. (2009) Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment. Molecular Pharmaceutics;6:60-73.
[19] Friend DR. (1991) Colon-specific drug delivery. Advanced Drug Delivery Reviews;7:149-199.
[20] Park JH, Saravanakumar G, Kim K, Kwon IC. (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Advanced Drug Delivery Reviews;62:28-41.
[21] Prajakta D, Ratnesh J, Chandan K, Suresh S, Grace S, Meera V, et al. (2009) Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. Journal of Biomedical Nanotechnology;5:445-455.
[22] Cerchiara T, Abruzzo A, Di Cagno M, Bigucci F, Bauer-Brandl A, Parolin C, et al. (2015) Chitosan based micro-and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods. European Journal of Pharmaceutics and Biopharmaceutics;92:112-119.
[23] Chaturvedi K, Kulkarni AR, Aminabhavi TM. (2011) Blend microspheres of poly (3-hydroxybutyrate) and cellulose acetate phthalate for colon delivery of 5-fluorouracil. Industrial & Engineering Chemistry Research;50:10414-10423.
[24] Chidambaram R. (2016) Application of rice husk nanosorbents containing 2, 4-dichlorophenoxyacetic acid herbicide to control weeds and reduce leaching from soil. Journal of the Taiwan Institute of Chemical Engineers;63:318-326.
[25] Bhattarai N, Gunn J, Zhang M. (2010) Chitosan-based hydrogels for controlled, localized drug delivery. Advanced Drug Delivery Reviews;62:83-99.
[26] Wu J, Sailor MJ. (2009) Chitosan Hydrogel‐Capped Porous SiO2 as a pH Responsive Nano‐Valve for Triggered Release of Insulin. Advanced Functional Materials;19:733-741.
[27] Lu H, Yang G, Ran F, Gao T, Sun C, Zhao Q, et al. (2020) Polymer-functionalized mesoporous carbon nanoparticles on overcoming multiple barriers and improving oral bioavailability of Probucol. Carbohydrate Polymers;229:115508.
[28] Samuel MS, Bhattacharya J, Raj S, Santhanam N, Singh H, Singh NP. (2019) Efficient removal of Chromium (VI) from aqueous solution using chitosan grafted graphene oxide (CS-GO) nanocomposite. International Journal of Biological Macromolecules;121:285-292.
[29] Samuel MS, Subramaniyan V, Bhattacharya J, Chidambaram R, Qureshi T, Singh NP. (2018) Ultrasonic-assisted synthesis of graphene oxide–fungal hyphae: an efficient and reclaimable adsorbent for chromium (VI) removal from aqueous solution. Ultrasonics Sonochemistry;48:412-417.
[30] Samuel MS, Jose S, Selvarajan E, Mathimani T, Pugazhendhi A. (2020) Biosynthesized silver nanoparticles using Bacillus amyloliquefaciens; Application for cytotoxicity effect on A549 cell line and photocatalytic degradation of p-nitrophenol. Journal of Photochemistry and Photobiology B: Biology;202:111642.
[31] Samuel MS, Subramaniyan V, Bhattacharya J, Parthiban C, Chand S, Singh NP. (2018) A GO-CS@ MOF [Zn (BDC)(DMF)] material for the adsorption of chromium (VI) ions from aqueous solution. Composites Part B: Engineering;152:116-125.
[32] Samuel MS, Shah SS, Bhattacharya J, Subramaniam K, Singh NP. (2018) Adsorption of Pb (II) from aqueous solution using a magnetic chitosan/graphene oxide composite and its toxicity studies. International Journal of Biological Macromolecules;115:1142-1150.
[33] Parthiban C, Sen D, Singh NP. (2018) Visible-Light-Triggered Fluorescent Organic Nanoparticles for Chemo-Photodynamic Therapy with Real-Time Cellular Imaging. ACS Applied Nano Materials;1:6281-6288.
[34] Sonaje K, Chuang EY, Lin KJ, Yen TC, Su FY, Tseng MT, et al. (2012) Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. Molecular Pharmaceutics;9:1271-1279.
[35] Popat A, Ross BP, Liu J, Jambhrunkar S, Kleitz F, Qiao SZ. (2012) Enzyme‐responsive controlled release of covalently bound prodrug from functional mesoporous silica nanospheres. Angewandte Chemie International Edition;51:12486-12489.
[36] Rao J, Khan A. (2013) Enzyme sensitive synthetic polymer micelles based on the azobenzene motif. Journal of the American Chemical Society;135:14056-14059.
[37] Fang X, Chen C, Liu Z, Liu P, Zheng N. (2011) A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres. Nanoscale;3:1632-1639.
[38] Zhao QF, Liu J, Zhu WQ, Sun CS, Di DH, Zhang Y, et al. (2015) Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Acta Biomater;23:147-156.
[39] Agarwal T, Narayana SN, Pal K, Pramanik K, Giri S, Banerjee I. (2015) Calcium alginate-carboxymethyl cellulose beads for colon-targeted drug delivery. International Journal of Biological Macromolecules;75:409-417.
[40] He Q, Zhang J, Shi J, Zhu Z, Zhang L, Bu W, et al. (2010) The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials;31:1085-1092.
[41] Gu J, Su S, Zhu M, Li Y, Zhao W, Duan Y, et al. (2012) Targeted doxorubicin delivery to liver cancer cells by PEGylated mesoporous silica nanoparticles with a pH-dependent release profile. Microporous and Mesoporous Materials;161:160-167.
[42] Wan L, Wang X, Zhu W, Zhang C, Song A, Sun C, et al. (2015) Folate-polyethyleneimine functionalized mesoporous carbon nanoparticles for enhancing oral bioavailability of paclitaxel. International Journal of Pharmaceutics;484:207-217.
[43] Zhang Y, Zhang H, Che E, Zhang L, Han J, Yang Y, et al. (2015) Development of novel mesoporous nanomatrix-supported lipid bilayers for oral sustained delivery of the water-insoluble drug, lovastatin. Colloids & Surfaces B Biointerfaces;128:77-85.
[44] Zhao Q, Liu J, Zhu W, Sun C, Di D, Zhang Y, et al. (2015) Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Acta Biomaterialia;23:147-156.
[45] Tang H, Guo J, Sun Y, Chang B, Ren Q, Yang W. (2011) Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. International Journal of Pharmaceutics;421:388-396.
[46] Popat A, Hartono SB, Stahr F, Jian L, Shi ZQ, Gao QL. (2011) Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale;3:2801-2818.
[47] Chai GH, Xu Y, Chen SQ, Cheng B, Hu FQ, You J, et al. (2016) Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology. ACS Applied Materials & Interfaces;8:5929-5940.
[48] Peng Y, Yadava P, Heikkinen AT, Parrott N, Railkar A. (2014) Applications of a 7-day Caco-2 cell model in drug discovery and development. European Journal of Pharmaceutical Sciences;56:120-130.
[49] Er-Yuan C, Kun-Ju L, Fang-Yi S, Fwu-Long M, Barnali M, Chiung-Tong C, et al. (2013) Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats. Journal of Controlled Release;172:513-522.